Economic evaluations of next-generation sequencing for targeted therapy in non-small cell lung cancer: a systematic review. [PDF]
Dai Z, Ye W, Zhou J, Tian L.
europepmc +1 more source
Trying to estimate a monetary value for qualy [PDF]
In this paper we study the feasibility of estimating a monetary value for a QALY (MVQ). Using two different surveys of the Spanish population (total n=892), we consider whether willingness to pay (WTP) is (approximately) proportional to the health gains ...
Jose Luis Pinto +2 more
core
Cost-effectiveness analysis of efavirenz versus ainuovirine in people living with HIV initiating first-line combination antiretroviral therapy. [PDF]
Yang C +5 more
europepmc +1 more source
QALYs: incorporating the rate of change in quality of life
The need for comparisons and economic evaluations between various health care interventions requires the evaluation of health-related quality of life. To ensure comparability in terms of the duration of any given condition, measures of quality have to ...
Katostara, Niki, Katostaras, Theofanis
core
The Conventional Cost-Effectiveness and Distributional Cost-Effectiveness of Semaglutide for Obesity Treatment. [PDF]
Kulkarni NS +5 more
europepmc +1 more source
Comparative effectiveness of nature-based social prescribing to alleviate loneliness in Spain: a decision analysis informed by the RECETAS trial. [PDF]
Papon V +11 more
europepmc +1 more source
Comparing Nerve Transfer Versus Tendon Transfer and Conservative Management for Restoring Finger Extension Following Tetraplegia: A Cost-Effectiveness Analysis. [PDF]
Arunachalam Sakthiyendran N +3 more
europepmc +1 more source
Quality of Life Changes in Respiratory Infection Trajectory with Point of Care Testing During Clinical Consultation. [PDF]
Rojas-Garcia P +12 more
europepmc +1 more source
Cost-utility of NeuroSAFE-guided RARP Versus Standard RARP in Men with Localised Prostate Cancer in the UK. [PDF]
Wang J +10 more
europepmc +1 more source
Cost-effectiveness of capivasertib plus abiraterone for PTEN-deficient metastatic hormone-sensitive prostate cancer in the United States. [PDF]
Weiss GJ.
europepmc +1 more source

